{"url_path":"/sec/cvm/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/725363/0001654954-26-004910-index.html","accession_number":"0001654954-26-004910","cik":"0000725363","ticker":"CVM","issuer_name":"CEL SCI CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/725363/0001654954-26-004910-index.html","primary_entity_key":"0000725363","primary_entity_name":"CEL SCI CORP"},"word_count":68,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n  \n\nExhibit No.\n\n \n\nDescription\n\n \n\n \n\n \n\n[10(sss)](cvm_ex10sss.htm)\n\n \n\n[Agreement with Amarox](cvm_ex10sss.htm)\n\n \n\n \n\n \n\n[99](cvm_ex99.htm)\n\n \n\n[Press Release re. Agreement with Amarox](cvm_ex99.htm)\n\n \n\n \n\n2\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: May 14, 2026\n\n \n\n \n\n**CEL-SCI CORPORATION**\n\n \n\n \n\n \n\n \n\n \n\n \n\nBy: \n/s/ Geert Kersten\n \n\n \n\n \nGeert Kersten\n \n\n \n\n \nChief Executive Officer\n \n\n \n\n \n\n3"}